Developer docs
API playgroundTry for free, no card

Search company profiles

CD&R LLP

Full company profile

uuid0000tfs

Namestring
CD&R LLP
Legal namestring
CD&R LLP
Company typeenum
Private
Founded yearint
1978
Descriptiontext

Clayton, Dubilier & Rice is a private investment firm founded in 1978 by Gene Clayton, Marty Dubilier, and Joe Rice that operates through its U.S. affiliate (Clayton, Dubilier & Rice, LLC, headquartered at 550 Madison Avenue, New York) and its U.K. limited liability partnership (CD&R LLP, headquartered in London). CD&R pursues large-scale control buyouts and strategic partnerships, deploying capital through private equity funds and serving management teams and boards of established businesses in industrial, healthcare, consumer, technology, and financial services end markets. The firm closed its $26 billion Fund XII in August 2023 and is targeting $26–28 billion for its next flagship fund, placing it among the largest-ever private equity fundraises. Its operational model pairs investment professionals with a network of Operating Advisors (former CEOs and executives of Fortive, Charles Schwab, P&G, Marsh McLennan, Trane, CRH, and other Fortune-level firms) and dedicated value-creation functions including Tech Value Creation (expanded May 2026), Portfolio Talent/Human Capital, and Portfolio Procurement.

CD&R generates revenue through private equity fund management — earning management fees and performance-based carried interest on capital managed on behalf of a global institutional investor base of university endowments, foundations, public and corporate pension funds, sovereign wealth funds, financial institutions, and family offices across Asia, Europe, Latin America, the Middle East, and the U.S. Its U.K. entity CD&R LLP is authorized and regulated by the Financial Conduct Authority and provides investment advisory services to the U.S. affiliate on U.K. and European investments. The firm's recent deal flow illustrates its scale and sector breadth: $10.3 billion Sealed Air (2026), €15–16 billion Opella (2024), $12.4 billion Truist Insurance (2024), $8.9 billion R1 RCM (2024), $8.8 billion Foundation Building Materials (2025), $5.8 billion Cornerstone Building Brands (2022), £10 billion Morrisons (2021), and ongoing Consortia deals with Stone Point, TowerBrook, CVC, TPG, American Securities, and Greenbriar. CD&R also operates an investor portal (LP Data Exchange) and runs the CD&R Foundation philanthropic arm and the Climate Leadership Program in partnership with Columbia University and Imperial Business School.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
private equity investing, buyout transactions, operational value creation, portfolio management, investment advisory services
NAICS code1 code
  • Portfolio Management and Investment Advice523940
Product category
Private Equity / Investment Management
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Private Equity Fund Management
TypeManaged Services
Description

CD&R is a private investment firm that manages capital on behalf of institutions and individuals worldwide through private equity funds. As a UK-regulated entity, CD&R LLP is subject to FCA MiFID prudential rules, indicating it earns management fees and performance-based carried interest from its managed funds. The firm invests in businesses across industrial, healthcare, consumer, technology, and financial services end markets.

cdr.com
2Advisory and Investment Services
TypeProfessional Services
Description

CD&R LLP provides investment advisory and other services to its U.S. affiliate, Clayton, Dubilier & Rice, LLC, comprising advice and support on the investigation, structuring, financing, monitoring, reporting, and disposition of U.K. and other European investments and investment opportunities.

cdr.com
Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others
Pricing details1 tier
1Flagship private equity fund target of $26 billion (potentially $28 billion including CD&R's own investment)
ModelOtherBilling cadenceMulti-year contract
Notes

CD&R Fund XII closed at $26 billion in August 2023. The new fund target could rank among the largest-ever private equity fundraises. Fund terms, management fees, and carried interest are not publicly disclosed.

bloomberg.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1CD&R Foundation
Description

The CD&R Foundation is the firm's philanthropic arm, supporting non-profit organizations focused on economic opportunity and employment in New York City and the UK, as referenced on the firm's main website navigation.

cdr.com
Core offering1 text field

CD&R LLP is a private investment firm that manages private equity capital on behalf of institutional and individual investors worldwide, executing large-scale control buyouts and strategic partnerships in industrial, healthcare, consumer, technology, and financial services end markets. The firm pairs investment advisory with an operational approach that combines financial expertise with deep operating capabilities, a broad Operating Advisor network, and dedicated portfolio support functions (Tech Value Creation, Human Capital, Procurement) to build long-term value in portfolio companies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • Multi-decade track record across numerous economic cycles; flagship Fund XII closed at $26 billion in August 2023, with the next fund targeted at $26 billion (potentially $28 billion).
+7 more records
Product overview1 text field

CD&R LLP is a single-firm private investment platform rather than a multi-product software suite. Its core offering is the CD&R private equity investment service, delivered through U.S. and U.K. entities (Clayton, Dubilier & Rice, LLC and CD&R LLP) from offices in New York and London, with add-on capabilities provided by the CD&R Tech Value Creation function (data and AI operating support for portfolio companies), the CD&R Climate Leadership Program (executive education partnership with Columbia University and Imperial Business School), the CD&R Foundation (philanthropy), and the Limited Partner Reporting System / LP Data Exchange investor portal. Underpinning this platform is a portfolio of operating companies spanning Industrials & Business Services (Artera Services, Belron, Brand Industrial Services, Cornerstone Building Brands, Indicor, Kalle Group, Multi-Color Corporation, OCS, Pursuit Aerospace, Resideo, Sealed Air, SIG plc, SOCOTEC, SunSource, Veritiv, Westbury Street Holdings, White Cap, Wilsonart, Wolseley UK) and Healthcare/Financial Services/Technology (Focus Financial Partners, R1 RCM, Presidio, Exclusive Networks, Epicor), plus historical exited investments (Solenis, Mauser, Beacon Roofing Supply, Hussmann, Atkore, Shearer's Foods, Opella, Brand Industrial Services, Covetrus, Vialto, Gentiva, Cornerstone Building Brands, etc.).

Product and service1 record
1CD&R Private Equity Investment Services
Scale indicator15 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCore Co-InvestorTypeStrategic or Co-development Partner
Description

CD&R and Greenbriar Equity Group completed acquisitions to create Pursuit Aerospace, a new leading supplier to the aerospace industry. In September 2025, Privet Capital sold Aeromet International to Pursuit Aerospace.

Strategic tierHealthcare Strategic PartnershipTypeStrategic or Co-development Partner
Description

Elevance Health and CD&R signed an agreement in April 2024 to launch a strategic partnership to advance primary care delivery, leading to the introduction of Mosaic Health as a national primary care delivery platform.

Strategic tierPortfolio Company Strategic ActionTypeStrategic or Co-development Partner
Description

Resideo (a CD&R portfolio company) agreed to acquire Snap One to expand presence in smart living products and distribution, announced in 2024.

Strategic tierPortfolio Company Strategic ActionTypeStrategic or Co-development Partner
Description

Performance Food Group Company (a CD&R portfolio company) announced an agreement to acquire Cheney Bros, Inc. in August 2024.

Strategic tierReal Estate / Office Lease PartnerTypeOthers
Description

CD&R pre-let the office component of GPE's 30 Duke Street St James's property in London in May 2025, part of a 67,700 sq ft building with total annual rent of £12.6 million.

Strategic tierEducational Partnership For Climate Leadership ProgramTypeStrategic or Co-development Partner
Description

CD&R launched a Climate Leadership Program in partnership with Columbia University in March 2025 and expanded it to Europe with Imperial Business School in March 2026, extending the Columbia partnership for a second year.

Recent move11 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global public alternative asset manager with a large-cap private equity franchise. Directly comparable to CD&R in mega-deal control buyouts (e.g., KKR was a co-bidder with CD&R for Stada in 2024) and in deploying $20B+ flagship funds across industrials, healthcare, and consumer sectors.

TypeBroad incumbent
Description

Largest alternative asset manager globally with a broad buyout, credit, and infrastructure platform. Competes with CD&R for the largest take-privates and corporate carve-outs and operates the largest flagship PE fund in the industry, setting the bar for the $26B+ flagship size CD&R is targeting.

TypeDirect peer
Description

Global alternative asset manager with a large private equity and credit platform. Apollo's Hybrid Value group is already a CD&R co-investor in Motor Fuel Group, and the firm is a direct competitor for large take-privates across industrial and financial services end markets.

TypeDirect peer
Description

Public global private equity firm investing across industrials, healthcare, consumer, technology, and financial services. Operates flagship buyout funds of similar scale to CD&R's and directly competes for the same mega-cap take-private opportunities in the US and Europe.

TypeDirect peer
Description

Global private equity firm with a long-standing buyout franchise. Bain (with Cinven) outbid CD&R for German generics company Stada in 2024, making it a direct competitor for European large-cap healthcare and consumer deals of the kind CD&R has historically pursued.

TypeDirect peer
Description

Public global private equity firm. TPG has been a frequent CD&R co-investor, most notably on the $4B Covetrus acquisition in 2022, and the two firms share a similar sector focus spanning healthcare, technology, and consumer.

TypeDirect peer
Description

European-headquartered global private equity firm that co-invests with CD&R (Epicor, Univar) and competed head-to-head on Stada. CVC is one of CD&R's closest comparables given the overlap in European large-cap take-privates and similar flagship fund sizes.

TypeDirect peer
Description

Private global investment firm focused on large-cap, control-oriented investments. Hellman & Friedman co-invests with CD&R in Belron alongside GIC and BlackRock, and the two firms compete directly for the largest take-privates in business services, financial services, and technology.

TypeDirect peer
Description

Private equity firm specializing in financial services. Stone Point is a flagship co-investor with CD&R in the $12.4B Truist Insurance Holdings acquisition and shares the operating-partner model that defines CD&R's value creation approach.

TypeDirect peer
Description

Global private equity growth investor with a multi-decade track record in large-cap control and minority investments. Comparable to CD&R in scale, sector breadth (industrials, healthcare, financial services, technology), and operating-partner orientation.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers25 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries6 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A61 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment36 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CD&R LLP

Private Equity / Investment Managementcdr.com

What CD&R LLP does

Clayton, Dubilier & Rice is a private investment firm founded in 1978 by Gene Clayton, Marty Dubilier, and Joe Rice that operates through its U.S. affiliate (Clayton, Dubilier & Rice, LLC, headquartered at 550 Madison Avenue, New York) and its U.K. limited liability partnership (CD&R LLP, headquartered in London). CD&R pursues large-scale control buyouts and strategic partnerships, deploying capital through private equity funds and serving management teams and boards of established businesses in industrial, healthcare, consumer, technology, and financial services end markets. The firm closed its $26 billion Fund XII in August 2023 and is targeting $26–28 billion for its next flagship fund, placing it among the largest-ever private equity fundraises. Its operational model pairs investment professionals with a network of Operating Advisors (former CEOs and executives of Fortive, Charles Schwab, P&G, Marsh McLennan, Trane, CRH, and other Fortune-level firms) and dedicated value-creation functions including Tech Value Creation (expanded May 2026), Portfolio Talent/Human Capital, and Portfolio Procurement.

CD&R generates revenue through private equity fund management — earning management fees and performance-based carried interest on capital managed on behalf of a global institutional investor base of university endowments, foundations, public and corporate pension funds, sovereign wealth funds, financial institutions, and family offices across Asia, Europe, Latin America, the Middle East, and the U.S. Its U.K. entity CD&R LLP is authorized and regulated by the Financial Conduct Authority and provides investment advisory services to the U.S. affiliate on U.K. and European investments. The firm's recent deal flow illustrates its scale and sector breadth: $10.3 billion Sealed Air (2026), €15–16 billion Opella (2024), $12.4 billion Truist Insurance (2024), $8.9 billion R1 RCM (2024), $8.8 billion Foundation Building Materials (2025), $5.8 billion Cornerstone Building Brands (2022), £10 billion Morrisons (2021), and ongoing Consortia deals with Stone Point, TowerBrook, CVC, TPG, American Securities, and Greenbriar. CD&R also operates an investor portal (LP Data Exchange) and runs the CD&R Foundation philanthropic arm and the Climate Leadership Program in partnership with Columbia University and Imperial Business School.

CD&R LLP firmographics

Firmographics
Name
CD&R LLP
Legal name
CD&R LLP
Website
https://www.cdr.com
Company type
Private
Founded year
1978
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

Where CD&R LLP is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices3 records

Markets served

CD&R LLP business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

  1. Private Equity Fund Management: CD&R is a private investment firm that manages capital on behalf of institutions and individuals worldwide through private equity funds. As a UK-regulated entity, CD&R LLP is subject to FCA MiFID prudential rules, indicating it earns management fees and performance-based carried interest from its managed funds. The firm invests in businesses across industrial, healthcare, consumer, technology, and financial services end markets.
  2. Advisory and Investment Services: CD&R LLP provides investment advisory and other services to its U.S. affiliate, Clayton, Dubilier & Rice, LLC, comprising advice and support on the investigation, structuring, financing, monitoring, reporting, and disposition of U.K. and other European investments and investment opportunities.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractFlagship private equity fund target of $26 billion (potentially $28 billion including CD&R's own investment)

Go-to-market motion3 records

Distribution channels3 records

CD&R LLP product offering

Product offering

Core offering

CD&R LLP is a private investment firm that manages private equity capital on behalf of institutional and individual investors worldwide, executing large-scale control buyouts and strategic partnerships in industrial, healthcare, consumer, technology, and financial services end markets. The firm pairs investment advisory with an operational approach that combines financial expertise with deep operating capabilities, a broad Operating Advisor network, and dedicated portfolio support functions (Tech Value Creation, Human Capital, Procurement) to build long-term value in portfolio companies.

Product overview

CD&R LLP is a single-firm private investment platform rather than a multi-product software suite. Its core offering is the CD&R private equity investment service, delivered through U.S. and U.K. entities (Clayton, Dubilier & Rice, LLC and CD&R LLP) from offices in New York and London, with add-on capabilities provided by the CD&R Tech Value Creation function (data and AI operating support for portfolio companies), the CD&R Climate Leadership Program (executive education partnership with Columbia University and Imperial Business School), the CD&R Foundation (philanthropy), and the Limited Partner Reporting System / LP Data Exchange investor portal. Underpinning this platform is a portfolio of operating companies spanning Industrials & Business Services (Artera Services, Belron, Brand Industrial Services, Cornerstone Building Brands, Indicor, Kalle Group, Multi-Color Corporation, OCS, Pursuit Aerospace, Resideo, Sealed Air, SIG plc, SOCOTEC, SunSource, Veritiv, Westbury Street Holdings, White Cap, Wilsonart, Wolseley UK) and Healthcare/Financial Services/Technology (Focus Financial Partners, R1 RCM, Presidio, Exclusive Networks, Epicor), plus historical exited investments (Solenis, Mauser, Beacon Roofing Supply, Hussmann, Atkore, Shearer's Foods, Opella, Brand Industrial Services, Covetrus, Vialto, Gentiva, Cornerstone Building Brands, etc.).

Differentiator

Problem solved

Functional benefit

Brands

  • CD&R Foundation: The CD&R Foundation is the firm's philanthropic arm, supporting non-profit organizations focused on economic opportunity and employment in New York City and the UK, as referenced on the firm's main website navigation.

Products and services

  • CD&R Private Equity Investment Services

Quantifiable outcome

  • Multi-decade track record across numerous economic cycles; flagship Fund XII closed at $26 billion in August 2023, with the next fund targeted at $26 billion (potentially $28 billion).
  • +7 more outcomes

Companies that use CD&R LLP

Customer profile

Named customers25 records

Ideal customer profiles2 records

CD&R LLP technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

CD&R LLP partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core co-investor, healthcare strategic partnership, portfolio company strategic action, real estate / office lease partner and educational partnership for climate leadership program.

  • Greenbriar Equity Groupcore co-investorStrategic or Co-development PartnerCD&R and Greenbriar Equity Group completed acquisitions to create Pursuit Aerospace, a new leading supplier to the aerospace industry. In September 2025, Privet Capital sold Aeromet International to Pursuit Aerospace.
  • Elevance Healthhealthcare strategic partnershipStrategic or Co-development PartnerElevance Health and CD&R signed an agreement in April 2024 to launch a strategic partnership to advance primary care delivery, leading to the introduction of Mosaic Health as a national primary care delivery platform.
  • Resideo Technologiesportfolio company strategic actionStrategic or Co-development PartnerResideo (a CD&R portfolio company) agreed to acquire Snap One to expand presence in smart living products and distribution, announced in 2024.
  • Performance Food Groupportfolio company strategic actionStrategic or Co-development PartnerPerformance Food Group Company (a CD&R portfolio company) announced an agreement to acquire Cheney Bros, Inc. in August 2024.
  • Great Portland Estates (GPE)real estate / office lease partnerOthersCD&R pre-let the office component of GPE's 30 Duke Street St James's property in London in May 2025, part of a 67,700 sq ft building with total annual rent of £12.6 million.
  • Columbia University / Imperial Business Schooleducational partnership for climate leadership programStrategic or Co-development PartnerCD&R launched a Climate Leadership Program in partnership with Columbia University in March 2025 and expanded it to Europe with Imperial Business School in March 2026, extending the Columbia partnership for a second year.

Scale indicators15 records

Recent moves11 records

Expansion highlights6 records

CD&R LLP competitors and assessment

Company assessment

Direct peers

  • KKR & Co. Global public alternative asset manager with a large-cap private equity franchise. Directly comparable to CD&R in mega-deal control buyouts (e.g., KKR was a co-bidder with CD&R for Stada in 2024) and in deploying $20B+ flagship funds across industrials, healthcare, and consumer sectors.
  • Apollo Global Management: Global alternative asset manager with a large private equity and credit platform. Apollo's Hybrid Value group is already a CD&R co-investor in Motor Fuel Group, and the firm is a direct competitor for large take-privates across industrial and financial services end markets.
  • The Carlyle Group: Public global private equity firm investing across industrials, healthcare, consumer, technology, and financial services. Operates flagship buyout funds of similar scale to CD&R's and directly competes for the same mega-cap take-private opportunities in the US and Europe.
  • Bain Capital: Global private equity firm with a long-standing buyout franchise. Bain (with Cinven) outbid CD&R for German generics company Stada in 2024, making it a direct competitor for European large-cap healthcare and consumer deals of the kind CD&R has historically pursued.
  • TPG Inc. Public global private equity firm. TPG has been a frequent CD&R co-investor, most notably on the $4B Covetrus acquisition in 2022, and the two firms share a similar sector focus spanning healthcare, technology, and consumer.
  • CVC Capital Partners: European-headquartered global private equity firm that co-invests with CD&R (Epicor, Univar) and competed head-to-head on Stada. CVC is one of CD&R's closest comparables given the overlap in European large-cap take-privates and similar flagship fund sizes.
  • Hellman & Friedman: Private global investment firm focused on large-cap, control-oriented investments. Hellman & Friedman co-invests with CD&R in Belron alongside GIC and BlackRock, and the two firms compete directly for the largest take-privates in business services, financial services, and technology.
  • Stone Point Capital: Private equity firm specializing in financial services. Stone Point is a flagship co-investor with CD&R in the $12.4B Truist Insurance Holdings acquisition and shares the operating-partner model that defines CD&R's value creation approach.
  • Warburg Pincus: Global private equity growth investor with a multi-decade track record in large-cap control and minority investments. Comparable to CD&R in scale, sector breadth (industrials, healthcare, financial services, technology), and operating-partner orientation.

Broad incumbents

  • Blackstone: Largest alternative asset manager globally with a broad buyout, credit, and infrastructure platform. Competes with CD&R for the largest take-privates and corporate carve-outs and operates the largest flagship PE fund in the industry, setting the bar for the $26B+ flagship size CD&R is targeting.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

CD&R LLP social profiles

Digital presence

CD&R LLP compliance and trust

Trust signal

Compliance7 records

CD&R LLP financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CD&R LLP leadership team

Management profile

Number of profiles

Profiles13 records

CD&R LLP subsidiaries and ownership

Company hierarchy

Subsidiaries6 records

CD&R LLP funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CD&R LLP M&A and investment

M&A and investment

M&A61 records

Investments36 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CD&R LLP

What does CD&R LLP do?

CD&R LLP is a private investment firm that manages private equity capital on behalf of institutional and individual investors worldwide, executing large-scale control buyouts and strategic partnerships in industrial, healthcare, consumer, technology, and financial services end markets. The firm pairs investment advisory with an operational approach that combines financial expertise with deep operating capabilities, a broad Operating Advisor network, and dedicated portfolio support functions (Tech Value Creation, Human Capital, Procurement) to build long-term value in portfolio companies.

Is CD&R LLP a public or private company?

CD&R LLP is a private company. It is classified as management employee owned and is currently operating.

When was CD&R LLP founded?

CD&R LLP was founded in 1978. It employs 101 to 250 people.

Where is CD&R LLP based?

CD&R LLP is headquartered in New York, United States, in the North America region.

How does CD&R LLP make money?

Two revenue lines are on record. Private Equity Fund Management is the primary driver. The others are advisory and Investment Services.

Who are CD&R LLP's main competitors?

Direct peers on record are KKR & Co., Apollo Global Management, The Carlyle Group, Bain Capital, TPG Inc., CVC Capital Partners, Hellman & Friedman, Stone Point Capital and Warburg Pincus. Blackstone is listed as a broad incumbent.

Does CD&R LLP have an API?

No public API is recorded for CD&R LLP.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Insider Trading & Hedge Fund DataMcKesson (MCK) Joins $5.8 Billion Option Care Health (OPCH) Acquisition. Is the Valuation Justified?McKesson agreed to acquire Option Care Health for $5.8 billion, valuing it at $32.05 per share, a 37% premium. The deal, with Clayton, Dubilier & Rice, gives McKesson 49% ownership and retains the right to acquire the remaining stake. The acquisition aims to expand McKesson's specialty healthcare services, but its financial success depends on improving Option Care's modest growth.American Banking and Market NewsOption Care Health (NASDAQ: OPCH) agrees to $32.05 buyout by CD R and McKessonOption Care Health agreed to a $32.05-per-share buyout by CD R and McKesson, valuing the company at about $5.8 billion. CD R holds a 51% stake, while McKesson invests $1.4 billion for 49%. The deal requires regulatory approvals and stockholder consent, with a first-half 2027 close expected.Markets DailyOption Care Health (NASDAQ:OPCH) Sees Strong Trading Volume – Time to Buy?CD&R and McKesson agreed to acquire Option Care Health for $32.05 per share in cash, a 37% premium to the prior closing price. The deal implies an enterprise value of about $5.8 billion, and shares traded at $31.0050 with unusually high volume. The stock remains below the offer price, reflecting regulatory and shareholder approval risks.Seeking AlphaOption Care: Booking My Gains Ahead Of Deal Completion (NASDAQ:OPCH)An investor in Option Care Health, acquired by CD&R and McKesson for $32.05 per share, is booking approximately 80% of gains. The investor cites regulatory risk and opportunity cost as reasons to lock in profits rather than wait for deal closure.AInvestStrength Seen in Option Care (OPCH): Can Its 32.7% Jump Turn into More Strength?Option Care Health shares rose 32.7% to $31 after CD&R and McKesson agreed to acquire it for $32.05 per share in cash, a 37% premium to the October 5 closing price. The deal values the company at about $5.8 billion, with expected quarterly EPS of $0.48 and revenue of $1.47 billion. The stock's price may not rise further without earnings estimate revisions.Pulse 2.0CD&R And McKesson To Acquire Option Care Health For $5.8 BillionCD&R and McKesson agreed to acquire Option Care Health for $32.05 per share, an enterprise value of about $5.8 billion. CD&R will hold a 51% majority stake, McKesson a 49% minority stake, and the deal is expected to close in the first half of 2027.MarketBeatOption Care Health (NASDAQ:OPCH) Sees Large Volume Increase - Should You Buy?Option Care Health saw a 5% volume increase on Wednesday, trading at $31.0050. CD&R and McKesson agreed to acquire the company for $32.05 per share in cash, a 37% premium. The deal faces regulatory and shareholder approval risks.MorningstarHealth Care Down on Rotation to Utilities — Health Care RoundupHealth-care stocks fell as investors rotated into utilities, while CD&R and McKesson agreed to buy Option Care Health for about $5.8 billion. Becton Dickinson struck a deal with the Trump administration to invest $19 billion in the U.S. in exchange for tariff relief.BenzingaOption Care Stock Trades Below McKesson's Deal Price — Here's the Spread - Option Care Health (NASDAQ:OPCOption Care Health agreed to a $32.05-per-share buyout by Clayton Dubilier & Rice and McKesson, valuing the company at about $5.8 billion. The stock trades at $31.05, leaving a $1 gap, and the deal is expected to close in the first half of 2027.InvestorsOption Health Care Skyrockets On $5.8 Billion McKesson, CD&R TakeoverMcKesson and CD&R agreed to acquire Option Health Care for $5.8 billion, with McKesson investing $1.4 billion for a 49% stake. The deal is expected to close in the first half of 2027, and Option Health Care shares rose over 30% to $31.06.